Publications by authors named "Pal Smith"

Claim this Profile
C
Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
Peder L Myhre, Are A Kalstad, Sjur H Tveit, Kristian Laake, Erik B Schmidt, Pal Smith

J Intern Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left ventricular mechanical dispersion in a general population: Data from the Akershus Cardiac Examination 1950 study.
Erika N Aagaard, Brede Kvisvik, Mohammad O Pervez, Magnus N Lyngbakken, Trygve Berge, Pål Smith

Eur Heart J Cardiovasc Imaging· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic screening for atrial fibrillation in a 65-year-old population with risk factors for stroke: data from the Akershus Cardiac Examination 1950 study.
Trygve Berge, Jon Brynildsen, Hege K Netmangen Larssen, Sophia Onarheim, Gaute R Jenssen, Pål Smith

Europace· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis.
Anja Wiedswang Horjen, Sara Reinvik Ulimoen, Jon Norseth, Jesper Hastrup Svendsen, Pål Smith

Scand J Clin Lab Invest· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study.
Trygve Berge, Magnus Nakrem Lyngbakken, Håkon Ihle-Hansen, Jon Brynildsen, Mohammad Osman Pervez, Pål Smith

BMJ Open· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation.
Anja Wiedswang Horjen, Ingebjørg Seljeflot, Trygve Berge, Pål Smith, Harald Arnesen

Thromb J· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Sensitivity Troponin I and Rhythm Outcome after Electrical Cardioversion for Persistent Atrial Fibrillation.
Anja Wiedswang Horjen, Sara Reinvik Ulimoen, Ingebjørg Seljeflot, Pål Smith, Harald Arnesen

Cardiology· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart and Brain Interactions--the Akershus Cardiac Examination (ACE) 1950 Study Design.
Trygve Berge, Thea Vigen, Mohammad Osman Pervez, Haakon Ihle-Hansen, Magnus Nakrem Lyngbakken, Pål Smith

Scand Cardiovasc J· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
Nicolai Tegn, Michael Abdelnoor, Lars Aaberge, Knut Endresen, Pål Smith

Lancet· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study.
Kristian Laake, Peder Myhre, Linn M Nordby, Ingebjørg Seljeflot, Michael Abdelnoor, Pål Smith

BMC Geriatr· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
Arnljot Tveit, Ingebjørg Seljeflot, Pal Smith, Harald Arnesen, Jesper Hastrup Svendsen

Immunobiology· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
Stuart J Connolly, Lars Wallentin, Michael D Ezekowitz, John Eikelboom, Jonas Oldgren, Pal J Smith

Circulation· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-arginine, asymmetric dimethylarginine and rhythm outcome after electrical cardioversion for atrial fibrillation.
Arnljot Tveit, Harald Arnesen, Pal Smith, Vibeke Bratseth, Ingebjørg Seljeflot

Cardiology· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy.
Marianne S Andresen, Irene Sandven, Cathrine Brunborg, Anne Mette Njaastad, Finn Strekerud, Pål Smith

Thromb Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of angiotensin receptor blockade on serial P-wave signal-averaged electrocardiograms after electrical cardioversion of persistent atrial fibrillation.
Finn Hegbom, Arnljot Tveit, Irene Grundvold, Harald Arnesen, Pal Smith

Europace· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of cardiac troponin T elevation in COPD exacerbation - a cross-sectional study.
Pål H Brekke, Torbjørn Omland, Stein Harald Holmedal, Pål Smith, Vidar Søyseth

BMC Pulm Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation.
Arnljot Tveit, Andreas Bollmann, Ingebjørg Seljeflot, Daniela Husser, Martin Stridh, Pål Smith

Thromb Haemost· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion.
Arnljot Tveit, Ingebjørg Seljeflot, Irene Grundvold, Michael Abdelnoor, Harald Arnesen, Pal Smith

Int J Cardiol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Less benefit from warfarin in diabetics after myocardial infarction?
Pål J Smith, Mette Hurlen, Michael Abdelnoor, Harald Arnesen

Cardiology· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrillatory rate response to candesartan in persistent atrial fibrillation.
Andreas Bollmann, Arnljot Tveit, Daniela Husser, Martin Stridh, Leif Sörnmo, Pål Smith

Europace· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive value of transthoracic echocardiographic variables for sinus rhythm maintenance after electrical cardioversion of atrial fibrillation. Results from the CAPRAF study, a prospective, randomized, placebo-controlled study.
Irene Grundvold, Arnljot Tveit, Pål Smith, Ingebjørg Seljeflot, Michael Abdelnoor

Cardiology· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation.
Pål H Brekke, Torbjørn Omland, Pål Smith, Vidar Søyseth

Respir Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation.
Arnljot Tveit, Ingebjørg Seljeflot, Irene Grundvold, Michael Abdelnoor, Pal Smith

Thromb Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial fibrillation and antithrombotic therapy in a 75-year-old population.
Arnljot Tveit, Michael Abdelnoor, Steve Enger, Pal Smith

Cardiology· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
Arnljot Tveit, Ingebjørg Seljeflot, Irene Grundvold, Michael Abdelnoor, Pal Smith

Am J Cardiol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis